Overview

A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994

Status:
Completed
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
Study is conducted to evaluate the long-term safety and tolerability of lacosamide (LCM) in patients receiving LCM in SP0994 [NCT01465997]. The study will enable collection of additional monotherapy safety data, and will facilitate access to treatment until commercial availability for monotherapy use.
Phase:
Phase 3
Details
Lead Sponsor:
UCB Biopharma S.P.R.L.
Collaborator:
Parexel
Treatments:
Lacosamide